Latest Breaking News On - Jessica ekeberg phone - Page 1 : vimarsana.com

AVITA Medical Achieves Milestone with First Case Using RECELL GO

VALENCIA, Calif., June 05, 2024 (GLOBE NEWSWIRE) AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin

United statesJim corbettZaheed hassanDrug administrationJosephm still burn centers incJosephm still burn centerBurn reconstruction centerBurn centerDoctors hospitalChief executive officerBurn centersSpray on skinPrivate securities litigation reform actAnnual reportChief financial officerAutologous cell harvesting

AVITA Medical to Host Investor Webinar Briefing

VALENCIA, Calif., May 16, 2024 (GLOBE NEWSWIRE) AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin

United statesJim corbettDavid otooleDrug administrationChief executive officerDavido tooleChief financial officerDaylight timeEastern standardSpray on skinMedia contactJessica ekeberg phone

AVITA Medical Updates Expected First Quarter 2024 Revenue

AVITA Medical Updates Expected First Quarter 2024 Revenue
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJim corbettDrug administrationChief executive officerEastern standard timeSpray on skinLooking statementsPrivate securities litigation reform actAnnual reportMedia contactJessica ekeberg phone

AVITA Medical Updates Expected First Quarter 2024 Revenue

AVITA Medical Updates Expected First Quarter 2024 Revenue
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

United statesJim corbettDrug administrationChief executive officerEastern standard timePrivate securities litigation reform actAnnual reportMedia contactJessica ekeberg phone

AVITA Medical Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance

22.02.2024 - VALENCIA, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) - AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today reported .

United statesJim corbettBiomedical advanced researchDevelopment authorityDrug administrationHuman servicesUs department of healthDrug administration foodChief executivePermeaderm biosynthetic wound matrixAssistant secretaryConference callEastern daylight timeSpray on skin cellsPrivate securities litigation reform actAnnual report